"Cholecystokinin" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A peptide, of about 33 amino acids, secreted by the upper INTESTINAL MUCOSA and also found in the central nervous system. It causes gallbladder contraction, release of pancreatic exocrine (or digestive) enzymes, and affects other gastrointestinal functions. Cholecystokinin may be the mediator of satiety.
| Descriptor ID |
D002766
|
| MeSH Number(s) |
D06.472.317.152 D12.644.120
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Cholecystokinin".
Below are MeSH descriptors whose meaning is more specific than "Cholecystokinin".
This graph shows the total number of publications written about "Cholecystokinin" by people in this website by year, and whether "Cholecystokinin" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 0 | 1 | 1 |
| 1996 | 0 | 1 | 1 |
| 1997 | 2 | 0 | 2 |
| 2000 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2004 | 1 | 0 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Cholecystokinin" by people in Profiles.
-
Lack of trophic pancreatic effects in humans with long-term administration of ximelagatran. Pancreas. 2006 Mar; 32(2):205-10.
-
Leptin action in the forebrain regulates the hindbrain response to satiety signals. J Clin Invest. 2005 Mar; 115(3):703-10.
-
Cholecystokinin- and cholecystokinin-B-receptor gene polymorphisms in panic disorder. J Neural Transm Suppl. 2004; (68):147-56.
-
An enteral therapy containing medium-chain triglycerides and hydrolyzed peptides reduces postprandial pain associated with chronic pancreatitis. Pancreatology. 2003; 3(1):36-40.
-
Leptin, gut, and food intake. Biochem Pharmacol. 2002 May 01; 63(9):1579-83.
-
Gastric effects of cholecystokinin and its interaction with leptin on brainstem neuronal activity in neonatal rats. J Pharmacol Exp Ther. 2000 Oct; 295(1):177-82.
-
Cholecystokinin modulates mucosal immunoglobulin A function. Surgery. 1997 Aug; 122(2):386-92; discussion 392-3.
-
Use of cholecystokinin to prevent the development of parenteral nutrition-associated cholestasis. JPEN J Parenter Enteral Nutr. 1997 Mar-Apr; 21(2):100-3.
-
Cholecystokinin increases bile acid synthesis with total parenteral nutrition but does not prevent stone formation. J Surg Res. 1997 Jan; 67(1):84-9.
-
Neuropeptide deficits in schizophrenia vs. Alzheimer's disease cerebral cortex. Biol Psychiatry. 1996 Jan 15; 39(2):82-91.